NTLA
Price
$10.75
Change
-$0.04 (-0.37%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
1.16B
87 days until earnings call
VOR
Price
$2.00
Change
-$0.07 (-3.38%)
Updated
Aug 11, 10:45 AM (EDT)
Capitalization
258.67M
Earnings call today
Interact to see
Advertisement

NTLA vs VOR

Header iconNTLA vs VOR Comparison
Open Charts NTLA vs VORBanner chart's image
Intellia Therapeutics
Price$10.75
Change-$0.04 (-0.37%)
Volume$68.49K
Capitalization1.16B
Vor Biopharma
Price$2.00
Change-$0.07 (-3.38%)
Volume$33.74K
Capitalization258.67M
NTLA vs VOR Comparison Chart in %
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTLA vs. VOR commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a StrongBuy and VOR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (NTLA: $10.79 vs. VOR: $2.07)
Brand notoriety: NTLA and VOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 85% vs. VOR: 9%
Market capitalization -- NTLA: $1.16B vs. VOR: $258.67M
NTLA [@Biotechnology] is valued at $1.16B. VOR’s [@Biotechnology] market capitalization is $258.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 1 FA rating(s) are green whileVOR’s FA Score has 0 green FA rating(s).

  • NTLA’s FA Score: 1 green, 4 red.
  • VOR’s FA Score: 0 green, 5 red.
According to our system of comparison, VOR is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 3 TA indicator(s) are bullish while VOR’s TA Score has 4 bullish TA indicator(s).

  • NTLA’s TA Score: 3 bullish, 5 bearish.
  • VOR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VOR is a better buy in the short-term than NTLA.

Price Growth

NTLA (@Biotechnology) experienced а -6.09% price change this week, while VOR (@Biotechnology) price change was -1.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.35%. For the same industry, the average monthly price growth was +31.87%, and the average quarterly price growth was +19.42%.

Reported Earning Dates

NTLA is expected to report earnings on Nov 06, 2025.

VOR is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+22.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.16B) has a higher market cap than VOR($259M). VOR YTD gains are higher at: 86.486 vs. NTLA (-7.461). VOR has higher annual earnings (EBITDA): -118.74M vs. NTLA (-530.8M). NTLA has more cash in the bank: 504M vs. VOR (60M). VOR has less debt than NTLA: VOR (30.8M) vs NTLA (119M). NTLA has higher revenues than VOR: NTLA (45.6M) vs VOR (0).
NTLAVORNTLA / VOR
Capitalization1.16B259M447%
EBITDA-530.8M-118.74M447%
Gain YTD-7.46186.486-9%
P/E RatioN/AN/A-
Revenue45.6M0-
Total Cash504M60M840%
Total Debt119M30.8M386%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLAVOR
RSI
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
78%
Bullish Trend 15 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITOF0.37N/A
+1.08%
Frontier Lithium
PREIF0.07N/A
+1.01%
Precipitate Gold Corp
LBLCF165.790.79
+0.48%
Loblaw Companies Limited
KOBNF29.57N/A
N/A
Kobe Bussan Co., Ltd.
DPZUF11.35N/A
N/A
Domino's Pizza Australia New Zealand

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been loosely correlated with CRSP. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if NTLA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-5.85%
CRSP - NTLA
65%
Loosely correlated
-1.72%
BEAM - NTLA
65%
Loosely correlated
-1.34%
RXRX - NTLA
56%
Loosely correlated
-0.92%
IDYA - NTLA
53%
Loosely correlated
+3.08%
ABCL - NTLA
53%
Loosely correlated
+0.24%
More

VOR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VOR has been loosely correlated with QSI. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if VOR jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VOR
1D Price
Change %
VOR100%
N/A
QSI - VOR
36%
Loosely correlated
-4.51%
CVAC - VOR
35%
Loosely correlated
-0.37%
NTLA - VOR
33%
Loosely correlated
-5.85%
XNCR - VOR
32%
Poorly correlated
-1.23%
ALEC - VOR
31%
Poorly correlated
+47.26%
More